Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
about
Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancerProgression of mouse skin carcinogenesis is associated with increased ERα levels and is repressed by a dominant negative form of ERαChemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.[Off-label use of alitretinoin].Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.Skin cancer in kidney transplant recipients.Psoriasis in Solid Organ Transplant Patients: Best Practice Recommendations from the Medical Board of the National Psoriasis Foundation.Acitretin systemic and retinoic acid 0.1% cream supression of basal cell carcinoma.Increased incidence and mortality associated with skin cancers after cardiac transplant.Alitretinoin--its use in intractable hand eczema and other potential indications.Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.A rare presentation of squamous cell carcinoma in a patient with PIBIDS-type trichothiodystrophy.The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients.A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.Neoplasms
P2860
Q34066208-CC758E4A-4970-4540-A219-7EA7E82D49AAQ34369167-79F013E6-B52F-44F6-BE9E-87A1226B9C96Q34406418-908B61CE-5F0D-4AE0-B6E1-B4ED45299C07Q35024462-1E411D43-0A7A-420C-AC53-677E70E00570Q35841941-12D9D9A0-3C33-4240-A146-873283AE14D8Q36705361-FE66E27D-2ADE-4C65-B144-041C25BCC3FEQ38210273-DA70EB77-1336-4CE5-8206-B18EC66F2C16Q40060986-23EB6C32-4ED7-4492-BC7F-F252AB97E358Q42105965-BD846376-247C-4AB9-9080-0FE873E8C3DBQ42490809-268028DC-AEFC-4B42-A0F8-42212D08736DQ42595956-76D60448-0D02-4AB0-BAB9-AC788BA6DB53Q46763769-BD3EB1E2-7998-4A1D-9B64-5B1AADD8FE40Q46838064-5FF00190-E42E-48B1-A91B-1C871AEF23ABQ47757569-4F27F70A-93DA-4475-9B3A-246CCAD37002Q49060314-1F098D52-FC12-4933-B8A3-B361C183C271Q52859211-0BC7BB94-DD5F-435B-AFB2-D1F75439F746Q56828372-8288697B-BEFF-436C-9190-95A180F60330
P2860
Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Oral retinoids for the prevent ...... randomized controlled trials.
@ast
Oral retinoids for the prevent ...... randomized controlled trials.
@en
type
label
Oral retinoids for the prevent ...... randomized controlled trials.
@ast
Oral retinoids for the prevent ...... randomized controlled trials.
@en
prefLabel
Oral retinoids for the prevent ...... randomized controlled trials.
@ast
Oral retinoids for the prevent ...... randomized controlled trials.
@en
P2093
P1476
Oral retinoids for the prevent ...... randomized controlled trials.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2005.06347.X
P407
P577
2005-03-01T00:00:00Z